Dr Evan Lewis is a Pediatric Neurologist and Clinical Neurophysiologist with expertise in epilepsy, epilepsy surgery, and medical cannabis for the treatment of neurologic disorders. He is the director of the Neurology Centre of Toronto (NCT) which he established in January 2017. At NCT, Evan treats children with a variety of neurological disorders as well as seeing adult patients for concussion, headaches and epilepsy.
He is an Assistant Professor with the Department of Pediatrics at the Hospital for Sick Children and the University of Toronto.
Evan's interest in medical cannabis began in 2013 while training at Miami Children’s Hospital – one of the major sites for the Epidiolex trials. He has significant clinical experience with medical cannabis in adults and children and is a member of the Canadian Consortium for the Investigation of Cannabinoids (CCIC), Canadian Childhood Cannabinoid Clinical Trials (C4T), and the Cannabinoid Research Initiative of Saskatchewan (CRIS).
He is is the Chief Medical Adviser for the Jamaican Medical Cannabis Corporation, member of the Expert Committee of the Medical Cannabis Clinicians Society (MCCS) in the United Kingdom and sits on the Advisory Councils for Cannabis Patient Advocacy & Support Services (CPASS) and MedCan.
With a strong commitment to research, Evan is a Fellow of the Royal College of Physicians of Canada and was the Tariff Chair of the Neurology Section for the Ontario Medical Association from 2017 - 2019. He sits on the Editorial Board for the Journal of Child Neurology’s Resident/Fellow Section and is an ad-hoc reviewer for the Canadian Journal of Neurological Sciences and Paediatrics & Child Health. His research and special interests include cannabinoids in the treatment of epilepsy and other neurological conditions and the delivery of novel virtual care models in neurology.
Evan has spoken extensively on cannabis in neurologic disorders nationally and internationally.